HopeStage
Back to all studies
CompletedNCT00475878

Escitalopram to ease depression and support buprenorphine treatment

About this titleRead the official source — NCT00475878
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
ProvidenceSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2006
Recruitment status
Completed
Enrollment listed in the registry
147
Sponsor
Butler Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00475878
Official title
Show the full official title

Antidepressants During Office-Based Buprenorphine

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Providence

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Butler Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including escitalopram and placebo.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies